AIMM is a preclinical stage company in the process of advancing 2 antibodies into the clinic.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Netherlands
Year Founded:
2004
Main Therapeutic Focus:
Oncology
Lead Product in Development:
AT1412
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
